Skip to content
healthcare.dev

GAVILAX

NDC 17856-0310, Polyethylene Glycol 3350, powder, for solution, from Atlantic Biologicals Corp..

Product NDC
17856-0310
Status
Listed
Labeler
Atlantic Biologicals Corp.
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA091077
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0310 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYETHYLENE GLYCOL 335017 g/17g

Pharmacologic classes

Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
17856-0310-11785603100150 CUP, UNIT-DOSE in 1 CASE (17856-0310-1) / 2 g in 1 CUP, UNIT-DOSE
17856-0310-21785603100272 POUCH in 1 CASE (17856-0310-2) / 2 g in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17856-0310 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0310 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17856-0310. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.